The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Conferences
Deel, M; Slemmons, K; Hinson, A; Crose, L; Kupraserkul, N; Oristian, K; Bentley, R; Linardic, C
Published in: PEDIATRIC BLOOD & CANCER
June 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
June 1, 2017
Volume
64
Start / End Page
S4 / S4
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Deel, M., Slemmons, K., Hinson, A., Crose, L., Kupraserkul, N., Oristian, K., … Linardic, C. (2017). The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. In PEDIATRIC BLOOD & CANCER (Vol. 64, pp. S4–S4). WILEY.
Deel, Michael, Katherine Slemmons, Ashley Hinson, Lisa Crose, Nina Kupraserkul, Kristianne Oristian, Rex Bentley, and Corinne Linardic. “The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.” In PEDIATRIC BLOOD & CANCER, 64:S4–S4. WILEY, 2017.
Deel M, Slemmons K, Hinson A, Crose L, Kupraserkul N, Oristian K, et al. The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. In: PEDIATRIC BLOOD & CANCER. WILEY; 2017. p. S4–S4.
Deel, Michael, et al. “The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.” PEDIATRIC BLOOD & CANCER, vol. 64, WILEY, 2017, pp. S4–S4.
Deel M, Slemmons K, Hinson A, Crose L, Kupraserkul N, Oristian K, Bentley R, Linardic C. The Transcriptional Co-Activator TAZ is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. PEDIATRIC BLOOD & CANCER. WILEY; 2017. p. S4–S4.
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
June 1, 2017
Volume
64
Start / End Page
S4 / S4
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis